PCSK9 mutations found in patients diagnosed with autosomal dominant hypercholesterolemia in the Netherlands

被引：0
|
作者：
Fouchier, SW
Peter, J
Lansberg, PJ
Kastelein, JJ
Defesche, JC
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [21] LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS
    Tada, Hayato
    Kawashiri, Masa-Aki
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1896 - 1896
  • [22] NEW GAIN OF FUNCTIONS MUTATIONS IN PCSK9 AND THEIR IMPACT IN FAMILIAL HYPERCHOLESTEROLEMIA
    AbiFadel, M.
    Rabes, J. -P.
    Guerin, M.
    Carreau, V.
    Carrie, A.
    Varret, M.
    Samson-Bouma, M. -E.
    Tosolini, L.
    Erlich, D.
    Couvert, P.
    Bonnefont-Rousselot, D.
    Bruckert, E.
    Prat, A.
    Seidah, N.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [23] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
  • [24] PCSK9: a new target for hypercholesterolemia
    Cariou, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 16 - 16
  • [25] PCSK9 and Hypercholesterolemia: Therapeutic Approach
    Obradovic, Milan
    Zaric, Bozidarka
    Sudar-Milovanovic, Emina
    Ilincic, Branislava
    Stokic, Edita
    Perovic, Milan
    Isenovic, Esma R.
    CURRENT DRUG TARGETS, 2018, 19 (09) : 1058 - 1067
  • [26] Targeting PCSK9 for the treatment of hypercholesterolemia
    Hedrick, Joseph A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 938 - 946
  • [27] PCSK9 inhibitors for treating hypercholesterolemia
    Pasta, Andrea
    Cremonini, Anna Laura
    Pisciotta, Livia
    Buscaglia, Angelo
    Porto, Italo
    Barra, Fabio
    Ferrero, Simone
    Brunelli, Claudio
    Rosa, Gian Marco
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 353 - 363
  • [28] PCSK9 IN FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    Lambert, G.
    Rye, K. -A.
    Burnett, J.
    Barter, P.
    Marais, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 31 - 31
  • [29] PCSK9 Inhibitors for Familial Hypercholesterolemia
    Lenahan, Christy M.
    Harringtoon, Deedra
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (08): : 577 - 578
  • [30] PCSK9 Antibodies for the Treatment of Hypercholesterolemia
    Gouni-Berthold, Ioanna
    Berthold, Heiner K.
    NUTRIENTS, 2014, 6 (12): : 5517 - 5533
12345